Potential role of polyribonucleotides in human neoplastic diseases.
In experimental models polyribonucleotides, either alone or in combination with various polycations, are potent immunomodulators, inducers of interferons, and antitumor compounds. However, emerging clinical and preclinical results suggest they may have useful therapeutic roles of types not yet described with interferons. Thus, further Phase I and Phase II clinical trials are warranted to define their potential usefulness in humans.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D011131:Polyribonucleotides / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D007369:Interferon Inducers; D011131:Polyribonucleotides